Chemoinformaics analysis of  Lysophosphatidyl-Inositol
| Molecular Weight | 572.629 | nRot | 21 |
| Heavy Atom Molecular Weight | 523.237 | nRig | 9 |
| Exact Molecular Weight | 572.296 | nRing | 1 |
| Solubility: LogS | -2.862 | nHRing | 0 |
| Solubility: LogP | 2.053 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 87 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 38 | No. of Aromatic Carbocycles | 0 |
| nHetero | 13 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 49 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 25 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 12 | No. of Arom Bond | 0 |
| nHA | 11 | APOL | 87.6769 |
| nHD | 7 | BPOL | 63.9411 |
| QED | 0.066 |
| Synth | 4.546 |
| Natural Product Likeliness | 0.629 |
| NR-PPAR-gamma | 0.066 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.334 |
| Pgp-sub | 0.223 |
| HIA | 0.956 |
| CACO-2 | -5.599 |
| MDCK | 0.0000399 |
| BBB | 0.201 |
| PPB | 0.897122 |
| VDSS | 0.489 |
| FU | 0.0502225 |
| CYP1A2-inh | 0.011 |
| CYP1A2-sub | 0.034 |
| CYP2c19-inh | 0.01 |
| CYP2c19-sub | 0.048 |
| CYP2c9-inh | 0.005 |
| CYP2c9-sub | 0.98 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.053 |
| CYP3a4-inh | 0.015 |
| CYP3a4-sub | 0.004 |
| CL | 0.917 |
| T12 | 0.434 |
| hERG | 0.283 |
| Ames | 0.045 |
| ROA | 0.002 |
| SkinSen | 0.364 |
| Carcinogencity | 0.204 |
| EI | 0.009 |
| Respiratory | 0.232 |
| NR-Aromatase | 0.087 |
| Antiviral | Yes |
| Prediction | 0.835972 |